BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35700108)

  • 1. A kaposiform haemangioendothelioma successfully treated with topical tacrolimus and compression bandaging.
    Nic Dhonncha E; Sadlier M
    Clin Exp Dermatol; 2022 Oct; 47(10):1870-1871. PubMed ID: 35700108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of kaposiform haemangioendothelioma successfully and safely treated with sirolimus.
    Wlodek C; Burt H; Shaw L
    Clin Exp Dermatol; 2017 Oct; 42(7):825-827. PubMed ID: 28703334
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study.
    Zhang G; Chen H; Gao Y; Liu Y; Wang J; Liu XY
    Br J Dermatol; 2018 May; 178(5):1213-1214. PubMed ID: 29388191
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of topical sirolimus on superficial Kaposiform haemangioendothelioma.
    Liu YX; Zhang J; Nie XL; Chen YL; Wang ZY; Xu ZG
    Australas J Dermatol; 2021 May; 62(2):e329-e331. PubMed ID: 33216947
    [No Abstract]   [Full Text] [Related]  

  • 5. Kasabach-Merritt syndrome, kaposiform haemangioendothelioma and platelet blockade.
    O'Rafferty C; O'Regan GM; Irvine AD; Smith OP
    Br J Haematol; 2015 Oct; 171(1):11. PubMed ID: 26114338
    [No Abstract]   [Full Text] [Related]  

  • 6. Kaposiform haemangioendothelioma in a nine-year-old boy with Kasabach-Merritt phenomenon.
    Zhang G; Gao Y; Liu X
    Br J Haematol; 2017 Oct; 179(1):9. PubMed ID: 28714059
    [No Abstract]   [Full Text] [Related]  

  • 7. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy.
    Der Sarkissian SA; Wong XL; Kossard S; Hong A; Sebaratnam DF
    Clin Exp Dermatol; 2022 Jan; 47(1):192-193. PubMed ID: 34480811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image Gallery: Kaposiform haemangioendothelioma.
    Moscarella E; Ametrano O; Diplomatico M; De Chiara C; Capasso M; Errico ME; Picciocchi R
    Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217
    [No Abstract]   [Full Text] [Related]  

  • 9. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
    Wang Y; Kong L; Sun B; Cui J; Shen W
    J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposiform haemangioendothelioma with Kasabach - Merritt phenomenon.
    Jandial A; Malhotra P
    Indian J Med Res; 2020 Nov; 152(Suppl 1):S226. PubMed ID: 35345221
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery.
    Jiang RS; Hu R
    Int J Clin Oncol; 2012 Oct; 17(5):512-6. PubMed ID: 21947597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma.
    Zhang X; Yang K; Chen S; Ji Y
    J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus therapy for children with problematic kaposiform haemangioendothelioma and tufted angioma.
    Tasani M; Ancliff P; Glover M
    Br J Dermatol; 2017 Dec; 177(6):e344-e346. PubMed ID: 28485019
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between extremity kaposiform hemangioendothelioma and lymphedema.
    Konczyk DJ; Goss JA; Maclellan RA; Greene AK
    Pediatr Dermatol; 2018 Jan; 35(1):e92-e93. PubMed ID: 29266383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Wang Z; Li K; Dong K; Xiao X; Zheng S
    Pediatr Blood Cancer; 2014 Aug; 61(8):1518-9. PubMed ID: 24482015
    [No Abstract]   [Full Text] [Related]  

  • 16. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW; Recht M; Silverman RA; Tom WL; Pope E
    Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
    Yao W; Li K; Wang Z; Dong K; Zheng S
    Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: successful treatment with sirolimus.
    Reichel A; Hamm H; Wiegering V; Wiewrodt B; Neubauer H; Ernestus K; Winkler B
    J Dtsch Dermatol Ges; 2017 Mar; 15(3):329-331. PubMed ID: 28220608
    [No Abstract]   [Full Text] [Related]  

  • 19. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine.
    Barabash-Neila R; García-Rodríguez E; Bernabeu-Wittel J; Bueno-Rodríguez I; Ramírez-Villar G; López-Gutierrez JC
    Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581
    [No Abstract]   [Full Text] [Related]  

  • 20. Kaposiform hemangioendothelioma: therapeutic efficacy for an enigmatic diagnosis.
    Blei F
    Pediatr Blood Cancer; 2015 Apr; 62(4):551-2. PubMed ID: 25559734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.